- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
This Article
Services
Google Scholar
PubMed
Acta Endocrinologica (Buc)
Moise LG, Marta DS, Rascu A, Moldoveanu E
Serum Lipoprotein-Associated Phospholipase A2 in Males With Metabolic Syndrome and Obstructive Sleep Apnea
Acta Endo (Buc) 2018, 14 (1): 36-42doi: 10.4183/aeb.2018.36
Context. Lipoprotein-associated phospholipase A2
(Lp-PLA2) is a novel biomarker for cardiovascular diseases
(CVD) risk estimation with high specificity for vascular
inflammation. Few studies have investigated Lp-PLA2 levels
in patients with metabolic syndrome (MetS) and obstructive
sleep apnea syndrome (OSAS).
Objective. This study aimed to evaluate the role of
Lp-PLA2 levels as a marker of vascular inflammation that
contributes to cardiometabolic dysfunction in patients with
MetS and OSAS.
Design. This is a prospective case-control study.
Subjects and Methods. 83 men were enrolled.
Following anthropometric measurements, laboratory
analysis and overnight sleep study, patients were divided
into three groups: MetS, OSAS with/without MetS. Serum
Lp-PLA2 levels were determined by ELISA method.
Results. Serum Lp-PLA2 levels were statistically
significant among the three groups and were higher in OSAS
with MetS group than those without MetS. A significant
positive relationship between increased Lp-PLA2 level and
CRP (C-reactive protein) and apnea–hypopnea index (AHI)
was found. Average oxygen saturation (AvO2) and the lowest
oxygen saturation were negatively correlated with Lp-PLA2.
The number of desaturation events, oxygen desaturation
index, AvO2, AHI and CRP were significant predictors of
Lp-PLA2.
Conclusions. Lp-PLA2 levels are associated with
OSAS severity and might play an important role in predicting
CVD in OSAS with/without MetS
Keywords: lipoprotein-associated phospholipase
A2, metabolic syndrome, obstructive sleep apnea,
cardiovascular disease risk.
Correspondence: Daciana-Silvia Marta, PhD, “Victor Babe?” National Institute of Pathology, Ultrastructural Pathology Department,
99-101 Splaiul Independen?ei, District 5, Code 050096, Bucharest, Romania. E-mail: daciana.marta@ivb.ro